News

Remdesivir Didn’t Help COVID-19 Patients: WHO Study

Remdesivir Didn’t Help COVID-19 Patients: WHO Study
Science
GENEVA (AP) — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries.

The results announced Friday do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival.

The drug has not been approved for COVID-19 in the U.S., but it was authorized for emergency use after  the previous study found  it shortened recovery time by five days on average. It’s approved for use against COVID-19 in the United Kingdom and Europe, and is among the treatments U.S. President Donald Trump received when he was infected earlier this month.

The WHO study involved more than 11,000 patients in 30 countries. About 2,750 were randomly assigned to get remdesivir. The rest got either the malaria drug hydroxychloroquine, the immune-system booster interferon, the antiviral combo lopinavir-ritonavir, or just usual care. The other drugs have largely been ruled out for COVID-19 by previous studies, but not remdesivir.

Death rates after 28 days, the need for breathing machines and time in the hospital were relatively similar for those given remdesivir versus usual care.

The results have not been published in a journal or reviewed by independent scientists, but were  posted on a site  researchers use to share results quickly.
Read more on The Huffington Post
News Topics :
Similar Articles :
World
Larger font Increase article font size A+ GENEVA — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID 19 patients,...
World
GENEVA The U.N. health agency says the world’s largest randomized trial of COVID 19 treatments found “conclusive evidence” that remdesivir, a drug used to treat U.S. President Donald Trump when...
World
Reuters The U.S. National Institutes of Health NIH on Friday said that data from its trial of Gilead Sciences Inc’s GILD.O remdesivir show that the drug offers...
Top Stories
Researchers released some good news about a possible treatment for coronavirus Wednesday evidence that the experimental drug remdesivir might help patients recover more quickly from the infection. The U.S....
Health
In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir has little or no effect on mortality for patients hospitalized with...